본문 바로가기
KERD
논문KCI 등재

Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes

Hydar El Jamaly|Guy D Eslick|Martin Weltman
대한간학회 (The korean Association for the Study of the Liver)|2022.01|Clinical and Molecular Hepatology|제28권 제1호|pp. 52-66|DOI 10.3350/cmh.2021.0205

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

HypertensionObesityDiabetes mellitusPregnancy complicationsNon-alcoholic fatty liver disease

초록

Background/Aims: Maternal and fetal outcomes in pregnant patients with Non-alcoholic fatty liver disease (NAFLD) have been largely unexplored. To determine the level of evidence associated with maternal and fetal outcomes in pregnant women with NAFLD. Methods: We conducted a comprehensive literature search. The studies included pregnant patients with a previous, current or subsequent diagnosis of NAFLD. We used a random-effects model using odds ratios (OR) with 95% confidence intervals (CI). Results: Twenty-two studies, with 13,641 female NAFLD patients were reviewed. The results highlight that NAFLD patients had a statistically significant increased likelihood of baseline diabetes mellitus (OR, 6.00; 95% CI, 2.21–16.31; P<0.001; n=7), baseline Hypertension (OR, 3.75; 95% CI, 2.13–6.59; P<0.001; n=4), gestational hypertension (OR, 1.83; 95% CI, 1.03–3.26; P=0.041; n=2), and pre-eclampsia (OR, 2.43; 95% CI, 1.46–4.04; P=0.001; n=3). The odds for a past and current history of gestational diabetes mellitus were OR, 3.78; 95% CI, 2.21–6.44; P<0.001; n=5 and OR, 3.23; 95% CI, 1.97– 5.31; P<0.001; n=6, respectively. As for fetal outcomes, pregnant NAFLD patients were significantly more likely to have a premature birth (OR, 2.02; 95% CI, 1.44–2.85; P<0.001; n=4), large for gestational age birth (OR, 2.01; 95% CI, 1.72–2.37; P<0.001; n=2) or a history of prior miscarriage or abortion (OR, 1.15; 95% CI, 1.02–1.30; P=0.02; n=2). Egger’s regression revealed no evidence of publication bias (P>0.05). Conclusions: This meta-analysis provides pooled evidence that NAFLD is associated with a substantial increase in maternal diabetic and hypertensive complications and multiple adverse fetal outcomes. This data is important for clinicians managing these patients before, during and after pregnancy.

Abstract

Background/Aims: Maternal and fetal outcomes in pregnant patients with Non-alcoholic fatty liver disease (NAFLD) have been largely unexplored. To determine the level of evidence associated with maternal and fetal outcomes in pregnant women with NAFLD. Methods: We conducted a comprehensive literature search. The studies included pregnant patients with a previous, current or subsequent diagnosis of NAFLD. We used a random-effects model using odds ratios (OR) with 95% confidence intervals (CI). Results: Twenty-two studies, with 13,641 female NAFLD patients were reviewed. The results highlight that NAFLD patients had a statistically significant increased likelihood of baseline diabetes mellitus (OR, 6.00; 95% CI, 2.21–16.31; P<0.001; n=7), baseline Hypertension (OR, 3.75; 95% CI, 2.13–6.59; P<0.001; n=4), gestational hypertension (OR, 1.83; 95% CI, 1.03–3.26; P=0.041; n=2), and pre-eclampsia (OR, 2.43; 95% CI, 1.46–4.04; P=0.001; n=3). The odds for a past and current history of gestational diabetes mellitus were OR, 3.78; 95% CI, 2.21–6.44; P<0.001; n=5 and OR, 3.23; 95% CI, 1.97– 5.31; P<0.001; n=6, respectively. As for fetal outcomes, pregnant NAFLD patients were significantly more likely to have a premature birth (OR, 2.02; 95% CI, 1.44–2.85; P<0.001; n=4), large for gestational age birth (OR, 2.01; 95% CI, 1.72–2.37; P<0.001; n=2) or a history of prior miscarriage or abortion (OR, 1.15; 95% CI, 1.02–1.30; P=0.02; n=2). Egger’s regression revealed no evidence of publication bias (P>0.05). Conclusions: This meta-analysis provides pooled evidence that NAFLD is associated with a substantial increase in maternal diabetic and hypertensive complications and multiple adverse fetal outcomes. This data is important for clinicians managing these patients before, during and after pregnancy.

참고문헌 (51)

  1. Younossi ZM, "Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis : implications for liver transplantation", Transplantation, 103, pp.22~27 (2019)
  2. Shulman GI, "Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease", N Engl J Med, 371, pp.1131~1141 (2014)
  3. Marchesini G, "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", Hepatology, 37, pp.917~923 (2003)
  4. Friedman GD, "CARDIA : study design, recruitment, and some characteristics of the examined subjects", J Clin Epidemiol, 41, pp.1105~1116 (1988)
  5. De Souza LR, "Non-alcoholic fatty liver disease in early pregnancy predicts dysglycemia in mid-pregnancy : prospective study", Am J Gastroenterol, 111, pp.665~670 (2016)
  6. Forbes S, "Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes", Diabetologia, 54, pp.641~647 (2011)
  7. Ajmera VH, "Gestational diabetes mellitus is strongly associated with non-alcoholic fatty liver disease", Am J Gastroenterol, 111, pp.658~664 (2016)
  8. Lee SM, "Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus", Diabetologia, 62, pp.238~248 (2019)
  9. Kubihal S, "Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus", J Diabetes Investig, 12, pp.877~885 (2021)
  10. Hershman M, "Implications of nonalcoholic fatty liver disease on pregnancy and maternal and child outcomes", Gastroenterol Hepatol(N Y), 15, pp.221~228 (2019)
  11. Stroup DF, "Meta-analysis of observational studies in epidemiology : a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology(MOOSE)group", JAMA, 283, pp.2008~2012 (2000)
  12. Herath RP, "Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women : a cross sectional analytical study", PLoS One, 14, pp.e0215326~ (2019)
  13. Hagström H, "Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease", Liver Int, 36, pp.268~274 (2016)
  14. Sarkar M, "Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes", J Hepatol, 73, pp.516~522 (2020)
  15. Mousa N, "Impact of non-alcoholic fatty liver disease on pregnancy", Br J Biomed Sci, 75, pp.197~199 (2018)
  16. Page LM, "A novel cause for abnormal liver function tests in pregnancy and the puerperium : non-alcoholic fatty liver disease", BJOG, 118, pp.1532~1535 (2011)
  17. Sattari M, "Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy", J Investig Med, 68, pp.743~747 (2020)
  18. Rosenbluth E, "Prevalence and predictors of NAFLD in pregnant women", Hepatology, 72(1), pp.987~ (2020)
  19. Ali A, "Non-alcoholic fatty liver disease in pregnancy and associated fetomaternal outcomes in a tertiary care hospital in Dhaka, Bangladesh", Hepatol Int, 12(2), pp.455~ (2018)
  20. Jung YM, "The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease", Liver Int, 40, pp.2417~2426 (2020)
  21. Lee SM, "Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight", PLoS One, 14, pp.e0221400~ (2019)
  22. Liu Y, "Association between history of abortion and nonalcoholic fatty liver disease in middleaged and elderly Chinese women", Ann Epidemiol, 23, pp.119~123 (2013)
  23. Wang J, "Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population", Clin Gastroenterol Hepatol, 19, pp.1258~1266 (2021)
  24. Lu J, "Age at menarche is associated with the prevalence of non-alcoholic fatty liver disease later in life", J Diabetes, 9, pp.53~60 (2017)
  25. Golabi P, "Association of parity in patients with chronic liver disease", Ann Hepatol, 17, pp.1035~1041 (2018)
  26. Ryu S, "Menopausal stages and non-alcoholic fatty liver disease in middle-aged women", Eur J Obstet Gynecol Reprod Biol, 190, pp.65~70 (2015)
  27. Bruno Ade S, "Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women", Climacteric, 17, pp.465~471 (2014)
  28. Liu SH, "Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women : results from NHANES III", J Gastroenterol, 48, pp.1151~1159 (2013)
  29. "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"[URL]
  30. Moga C, "Development of a quality appraisal tool for case series studies using a modified Delphi technique" (2012), Edmonton: Institute of Health Economics
  31. Sterne JA, "ROBINS-I : a tool for assessing risk of bias in nonrandomised studies of interventions", BMJ, 355, pp.i4919~ (2016)
  32. Guyatt GH, "GRADE : an emerging consensus on rating quality of evidence and strength of recommendations", BMJ, 336, pp.924~926 (2008)
  33. DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)
  34. Schroll JB, "Dealing with substantial heterogeneity in cochrane reviews. Cross-sectional study", BMC Med Res Methodol, 11, pp.22~ (2011)
  35. Sterne JA, "Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials", BMJ, 342, pp.d4002~ (2011)
  36. Birkenfeld AL, "Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes", Hepatology, 59, pp.713~723 (2014)
  37. Rich NE, "Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 16, pp.198~210 (2018)
  38. Vernon G, "Systematic review : the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults", Aliment Pharmacol Ther, 34, pp.274~285 (2011)
  39. Bennet L, "Country of birth modifies the association of fatty liver index with insulin action in Middle Eastern immigrants to Sweden", Diabetes Res Clin Pract, 110, pp.66~74 (2015)
  40. Barrett ES, "Differences in ovarian hormones in relation to parity and time since last birth", Fertil Steril, 101, pp.1773~1780 (2014)
  41. Bellamy L, "Type 2 diabetes mellitus after gestational diabetes : a systematic review and metaanalysis", Lancet, 373, pp.1773~1779 (2009)
  42. Dabelea D, "Maternal environment and the transgenerational cycle of obesity and diabetes", Diabetes, 60, pp.1849~1855 (2011)
  43. Stamnes Køpp UM, "The associations between maternal prepregnancy body mass index or gestational weight change during pregnancy and body mass index of the child at 3 years of age", Int J Obes(Lond), 36, pp.1325~1331 (2012)
  44. Luo J, "Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults", Nutr Metab(Lond), 15, pp.79~ (2018)
  45. Sibiak R, "Placental lactogen as a marker of maternal obesity, diabetes, and fetal growth abnormalities : current knowledge and clinical perspectives", J Clin Med, 9, pp.1142~ (2020)
  46. Kc K, "Gestational diabetes mellitus and macrosomia : a literature review", Ann Nutr Metab, 66(2), pp.14~20 (2015)
  47. Cobo T, "Risk factors for spontaneous preterm delivery", Int J Gynaecol Obstet, 150, pp.17~23 (2020)
  48. Granese R, "Preterm birth : seven-year retrospective study in a single centre population", Ital J Pediatr, 45, pp.45~ (2019)
  49. Berger H, "Impact of diabetes, obesity and hypertension on preterm birth : population-based study", PLoS One, 15, pp.e0228743~ (2020)
  50. Metwally M, "Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence", Fertil Steril, 90, pp.714~726 (2008)
  51. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)

관련 논문AI추천

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?김원, Seung Mi Lee대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제1호Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment권자영대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제1호Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods김원, 김경민, Byoung Jae Kim, Chan-Wook Park, Errol R. Norwitz, Eun Saem Choi, Ig Hwan Oh, Ja Nam Koo, Joong Shin Park, Sae Kyung Joo, Sang Youn Kim, Seung Mi Lee, Sue Shin, Suhyun Hwangbo, Sun Min Kim, Taesung Park, Young Mi Jung대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제1호Global incidence of adverse clinical events in nonalcoholic fatty liver disease: A systematic review and meta-analysisChristopher D. Stave, David M. Le, Fanpu Ji, Hansen Dang, KeeSeok Lee, Michael H. Le, Mindie H. Nguyen, Ramsey Cheung, Takanori Ito, Thomas C. Baez, Vy H. Nguyen, Yee Hui Yeo, Yuankai Wu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver diseaseAnand Kulkarni, Arun J Sanyal, Cheng Han Ng, Chin Meng Khoo, Daniel Q Huang, Darren Jun Hao Tan, Kai En Chan, Lay Hoon Goh, Lung-Yi Loey Mak, Mark Chan, Mark Muthiah, Mohammad Shadab Siddiqui, Nicholas WS Chew, Pei Chen Tsai, Rebecca Wenling Zeng, Wen Hui Lim, Yip Han Chin, Zheng Jye Ling대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제3호Mortality and Cardiovascular Outcomes in Patients with MAFLD Compared with Patients with MASLD: A Systematic Review and Meta-AnalysisAn Jihyun, Kim Seon-Ok, Kim Ye Rim, Na Seong Kyun, Shim Ju Hyun, Yang Jiwon거트앤리버 소화기연관학회협의회 · Gut and Liver2026 · 제20권 제1호

이 간행물의 다른 논문 (10건)

The management of post-transplantation recurrence of hepatocellular carcinomaMarco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin, Luckshi Rajendran, Tommy Ivanicspp. 1-16Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virusJun Sik Yoon, 이민종, Yuri Cho, Sun Woong Kimpp. 17-30Current knowledge about biomarkers of acute kidney injury in liver cirrhosisYeon Seok Seo, Han Ah Leepp. 31-46Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?Seung Mi Lee, 김원pp. 47-49Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment권자영pp. 50-51
원문 보기